Liang Kung-Hao, Yeh Ta-Sen, Wu Ren-Chin, Yeh Chun-Nan, Yeh Chau-Ting
Liver Research Center, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan, R.O.C.
Department of General Surgery, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan, R.O.C.
Oncol Lett. 2017 Jun;13(6):4215-4223. doi: 10.3892/ol.2017.5991. Epub 2017 Apr 5.
Cholangiocarcinoma is a rare, sporadic and aggressive type of cancer. The genetic basis of cholangiocarcinoma remains poorly understood. The present study investigated the prognostic role of the N-acetylgalactosaminyltransferase 14 ()-rs9679162 genotype, an effective therapeutic response predictor for hepatocellular carcinoma in patients with cholangiocarcinoma receiving surgical resection. A cohort of patients with intrahepatic or perihilar cholangiocarcinoma (n=112) were retrospectively recruited. Of these patients, 31.3, 49.1 and 19.6% had 'TT', 'TG' and 'GG' genotypes, respectively. The patient's genotype distributions did not deviate significantly from those of the ethnic reference cohorts, HapMap-Chinese Han Beijing and Chinese Han Metropolitan Denver. The genotype 'TT' was associated with unfavorable overall survival in univariate analysis (P=0.023). Furthermore, two tumor characteristics, perineural and vascular invasion, were independently associated with unfavorable overall survival (P=0.001 and P=0.002, respectively). The 'TT' genotypes were independently associated with two known predictors of unfavorable prognosis, perineural invasion (P=0.035) and lymph node metastasis (P=0.005) in a multivariate linear regression analysis. When compared with the two reference genotype cohorts, the 'TT' genotype was significantly higher in patients with perineural invasion (P=0.049, Beijing cohort; P=0.034, Denver cohort). Similar enrichment of the 'TT' genotype was also revealed in patients with lymph node metastasis (P=0.046, Beijing cohort; P=0.032 Denver cohort). In conclusion, the G-rs9679162 'TT' genotype was associated with perineural invasion and lymph node metastasis, as well as unfavorable overall survival in patients with resected cholangiocarcinoma.
胆管癌是一种罕见、散发且侵袭性强的癌症类型。胆管癌的遗传基础仍知之甚少。本研究调查了N - 乙酰半乳糖胺基转移酶14()-rs9679162基因型在接受手术切除的胆管癌患者中的预后作用,该基因型是肝细胞癌有效治疗反应的预测指标。回顾性招募了一组肝内或肝门周围胆管癌患者(n = 112)。在这些患者中,分别有31.3%、49.1%和19.6%的患者具有“TT”、“TG”和“GG”基因型。患者的基因型分布与种族参考队列HapMap - 中国汉族北京人群和中国汉族丹佛都市人群无显著差异。在单因素分析中,“TT”基因型与不良总生存期相关(P = 0.023)。此外,神经周围侵犯和血管侵犯这两个肿瘤特征与不良总生存期独立相关(分别为P = 0.001和P = 0.002)。在多因素线性回归分析中,“TT”基因型与两个已知的不良预后预测指标神经周围侵犯(P = 0.035)和淋巴结转移(P = 0.005)独立相关。与两个参考基因型队列相比,神经周围侵犯患者中“TT”基因型显著更高(北京队列P = 0.049;丹佛队列P = 0.034)。在淋巴结转移患者中也发现了类似的“TT”基因型富集现象(北京队列P = 0.046;丹佛队列P = 0.032)。总之,G - rs9679162“TT”基因型与神经周围侵犯、淋巴结转移以及手术切除胆管癌患者的不良总生存期相关。